C. Mannu

发表

Past, present and future treatment strategies in peripheral T-cell lymphomas

S. Pileri, P. Zinzani, P. Piccaluga, 2014 .

Hsa-miR-15a and Hsa-miR-16-1 Expression Is Not Related to Proliferation Centers Abundance and Other Prognostic Factors in Chronic Lymphocytic Leukemia

S. Pileri, P. Piccaluga, C. Agostinelli, 2013, BioMed research international.

Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial

M. Federico, G. Gaidano, P. Piccaluga, 2014, Clinical Cancer Research.

The role of molecular biology in the diagnosis of lymphoid neoplasms.

S. Pileri, E. Sabattini, M. Pizzi, 2014, Frontiers in bioscience.

CDKN1B/p27 expression in peripheral T cell lymphoma not otherwise specified

S. Pileri, E. Sabattini, P. Zinzani, 2010, Journal of Clinical Pathology.

CDKN 1 B / p 27 expression in peripheral T cell lymphoma not otherwise specified

S. Pileri, E. Sabattini, P. Zinzani, 2022 .

Minimal residual disease (MRD) in non‐Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network

R. Foà, P. Piccaluga, C. Agostinelli, 2019, Hematological oncology.

Ficoll‐hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis

P. Piccaluga, C. Agostinelli, S. Ferrero, 2018, International journal of laboratory hematology.

Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network

G. Gaidano, C. Pott, C. Agostinelli, 2021, HemaSphere.

Original Article Use of IGK gene rearrangement analysis for clonality assessment of lymphoid malignancies: a single center experience

S. Pileri, E. Sabattini, P. Piccaluga, 2011 .

Use of IGK gene rearrangement analysis for clonality assessment of lymphoid malignancies: a single center experience.

S. Pileri, E. Sabattini, P. Piccaluga, 2011, American journal of blood research.

Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature

S. Pileri, E. Sabattini, P. Piccaluga, 2011, Journal of medical case reports.

Pathobiology of Anaplastic Large Cell Lymphoma

S. Pileri, E. Sabattini, G. Inghirami, 2011, Advances in hematology.

Comparison of different DNA extraction methods from peripheral blood cells: advice from the Fondazione Italiana Linfomi Minimal Residual Disease Network

S. Pileri, G. Gaidano, E. Sabattini, 2016, Leukemia & lymphoma.

Prognostic Markers in Peripheral T-Cell Lymphoma

S. Pileri, E. Sabattini, P. Piccaluga, 2010, Current hematologic malignancy reports.

The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies

S. Pileri, E. Sabattini, P. Piccaluga, 2014, Therapeutic advances in hematology.

Biology and treatment of follicular lymphoma

S. Pileri, E. Sabattini, P. Zinzani, 2009, Expert review of hematology.

SNPs Array Karyotyping Reveals a Novel Recurrent 20p13 Amplification in Primary Myelofibrosis

S. Pileri, F. Alesiani, P. Piccaluga, 2011, PloS one.

Molecular profiling improves classification and prognostication of nodal peripheral T-cell lymphomas: results of a phase III diagnostic accuracy study.

J. Vose, S. Pileri, M. Federico, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Large cell non Hodgkin’s lymphoma: what is new in the WHO classification?

S. Pileri, E. Sabattini, P. Piccaluga, 2009 .

Gene expression profiling of peripheral T-cell lymphoma: from bench to bedside

S. Pileri, P. Piccaluga, C. Agostinelli, 2009 .

Distinctive Histogenesis and Immunological Microenvironment Based on Transcriptional Profiles of Follicular Dendritic Cell Sarcomas

Giovanna Motta, Claudio Agostinelli, Juan Rosai, 2017, Molecular Cancer Research.

Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition

S. Pileri, C. Croce, L. Pagano, 2014, Leukemia.

Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified

S. Pileri, C. Croce, E. Sabattini, 2014, Blood Cancer Journal.

Pathobiology of Hodgkin Lymphoma

S. Pileri, E. Sabattini, P. Piccaluga, 2010, Advances in hematology.

CDKN1B/ p27 expression in peripheral T cell lymphoma not otherwise speciﬁed

S. Pileri, E. Sabattini, P. Zinzani, 2022 .

Aberrant expression of CD10 and BCL6 in mantle cell lymphoma

M. Rugge, M. Fassan, E. Sabattini, 2017, Histopathology.

Comparison of two real‐time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real‐time quantitative polymerase chain reaction performance

R. Foà, G. Gaidano, P. Piccaluga, 2014, Hematological oncology.

A Case of Sinonasal Extranodal NK/T-Cell Lymphoma with Indolent Behaviour and Low-Grade Morphology

S. Pileri, E. Sabattini, R. Valli, 2014 .

Primary pulmonary T-cell lymphoproliferative disorders with a limited-stage, low proliferative index, and unusual clinical behavior: two cases of a rare occurrence

S. Pileri, E. Sabattini, C. Agostinelli, 2022, Virchows Archiv.

Myeloid Nuclear Differentiation Antigen (MNDA): an aid in differentiating lymphoplasmayctic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation.

E. Sabattini, C. Agostinelli, F. Bacci, 2022, Human Pathology.

Biology and treatment of follicular lymphoma

S. Pileri, E. Sabattini, P. Zinzani, 2009, Expert review of hematology.